Switch to:
More From Other Websites
Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX) to Ring The Nasdaq Stock Market Opening Bell Feb 02 2016
Pacira Pharma upgraded by BofA/Merrill Jan 29 2016
Pacira Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : January 22,... Jan 22 2016
Pacira Pharmaceuticals, Inc. – Value Analysis (NASDAQ:PCRX) : January 12, 2016 Jan 12 2016
Pacira Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : January 12,... Jan 12 2016
PACIRA PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Jan 08 2016
PACIRA PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 07 2016
Pacira Pharmaceuticals Reports Estimated Full-Year 2015 Total Revenue of $249.0 Million Jan 07 2016
Pacira Pharmaceuticals Reports Estimated Full-Year 2015 Total Revenue of $249.0 Million Jan 07 2016
Pacira Pharmaceuticals, Inc. to Present at the 34th Annual J.P. Morgan Healthcare Conference Dec 28 2015
Pacira Pharmaceuticals, Inc. to Present at the 34th Annual J.P. Morgan Healthcare Conference Dec 28 2015
Pacira Rose on the FDA’s Favorable Decision on EXPAREL Dec 21 2015
PACIRA PHARMACEUTICALS, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant,... Dec 18 2015
Pacira Resolves Litigation Related to Exparel with the FDA Dec 15 2015
What's next for Valeant? Dec 15 2015
Pacira Pharma Soars on Settled FDA Case Dec 15 2015
Pacira Pharmaceuticals (PCRX) Stock Surges After Regulators Resolve Free Speech Dispute Dec 15 2015
Skyepharma skips on Pacira's Exparel agreement with FDA Dec 15 2015


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK